Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer

CAMBRIDGE, Mass., September 14, 2026--Vyome Holdings, Inc. (Nasdaq: HIND) ("Vyome" or the "Company"), a clinical-stage biopharmaceutical company focused on developing differentiated therapies for immuno-inflammatory and rare disease conditions, today announced the appointment of senior financial executive Jerry Leonard, CPA, MBA, as Chief Financial Officer. Mr. Leonard has assumed the role from September 1st, 2026 and will oversee the Company’s financial operations, financial reporting, accounti